Efavirenz, Emtricitabine and Tenofovir Disoproxil
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
NADAC/unit
$1.3116
No Shortage
Tier 1: 19.8%
6 Manufacturers
6 ANDAs
Generic Manufacturers
AUROBINDO PHARMA LTDCIPLA LTDHETERO LABS LTD UNIT VLAURUS LABS LTDMACLEODS PHARMACEUTICALS LTDTEVA PHARMACEUTICALS USA
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.